GlassScriptPhysician profile
Heather Lynn Darmetko
NPI 1073935409
$1,862.26
in general payments reported to CMS, 2019-2025
13 companies · $38.08 in 2025
The $38.08 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $375 · 2022: $228 · 2023: $1,011 · 2024: $211 · 2025: $38.08.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,260.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,259.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $466.39 | 2021-2024 | Xtampza, Belbuca |
| Medtronic, INC. | $443.59 | 2021-2025 | Intellis Adaptivestim, Accurian |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $331.55 | 2023-2024 | Relistor |
| Boston Scientific Corporation | $199.56 | 2023 | Wavewriter Alpha Prime 16 |
| Abbott Laboratories | $133.21 | 2021-2024 | Proclaim, Eterna |
| Scilex Pharmaceuticals INC. | $80.71 | 2021-2022 | |
| Biodelivery Sciences International, INC. | $63.53 | 2021 | |
| Hikma Pharmaceuticals USA | $44.14 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $27.31 | 2022 | |
| Nevro Corp. | $21.76 | 2024 | Senza |
| Grt US Holding, INC. | $18.75 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.72 | 2025 | Trintellix |
| Bioventus LLC | $14.04 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Darmetko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.